Michael G Bartlett
Overview
Explore the profile of Michael G Bartlett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
803
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu L, Schaefer K, King G, Xie Z, Bartlett M
J Pharm Sci
. 2025 Feb;
:103708.
PMID: 40015511
Multidrug resistance mediated by P-glycoprotein (Pgp) is a significant obstacle to cancer chemotherapy. Taxane drugs, including paclitaxel, docetaxel, and cabazitaxel, are used to treat multiple types of cancer. All taxane...
2.
Finnerty M, Leach 3rd F, Zakharia Y, Nepple K, Bartlett M, Henry M, et al.
Sci Rep
. 2024 Sep;
14(1):22069.
PMID: 39333185
Docetaxel is commonly used for treatment of castration-resistant prostate cancer. Unfortunately, many prostate cancer patients develop resistance to docetaxel. Clinical markers less invasive than biopsies, such as blood samples, would...
3.
Bartlett M
J Chromatogr A
. 2024 Sep;
1736:465378.
PMID: 39293276
There has been a significant increase in the use of hydrophilic interaction liquid chromatography (HILIC) to separate oligonucleotides. This rise in the use of HILIC has correlated to the increasing...
4.
Bokhtia R, Pham A, Gupta K, Warang S, Venugopal N, Shakuja R, et al.
Chembiochem
. 2024 Jul;
25(20):e202400376.
PMID: 39073289
New Ursolic Acid (UA) conjugates were synthesized using optimized synthetic protocols through the molecular hybridization approach at C-3 and C-28. This resulted in the targeted molecules being produced in good...
5.
Friedman E, Falade L, Bartlett M
AAPS J
. 2024 Jul;
26(5):85.
PMID: 39043991
The effectiveness of the regulatory initiatives, strategies, and incentives put forth in the first two authorizations of the Generic Drug User Fees Act (GDUFA) were evaluated using factors including the...
6.
Srinivas N, Kallem R, Bartlett M
Biomed Chromatogr
. 2024 Jul;
38(9):e5954.
PMID: 38962861
Given the inherent complexities of bioanalysis, the role of incurred sample reanalysis (ISR) is increasingly appreciated in regulatory bioanalysis. Incurred sample reanalysis has evolved as an integral part of an...
7.
Mensah G, Schaefer K, Roberts A, King G, Bartlett M
J Pharm Sci
. 2024 Mar;
113(7):1960-1974.
PMID: 38527618
The efficacy of many cancer drugs is hindered by P-glycoprotein (Pgp), a cellular pump that removes drugs from cells. To improve chemotherapy, drugs capable of evading Pgp must be developed....
8.
Srinivas N, Bartlett M
Biomed Chromatogr
. 2024 Feb;
38(3):e5843.
PMID: 38316616
No abstract available.
9.
Mensah G, Schaefer K, Bartlett M, Roberts A, King G
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003248
P-glycoprotein (Pgp) plays a pivotal role in drug bioavailability and multi-drug resistance development. Understanding the protein's activity and designing effective drugs require insight into the mechanisms underlying Pgp-mediated transport of...
10.
Guimaraes G, Saad J, Annavarapu V, Bartlett M
J Am Soc Mass Spectrom
. 2023 Nov;
34(12):2691-2699.
PMID: 37978939
The implementation of fluoroalcohol/alkylamine mobile phase systems in oligonucleotide LC-MS provides a good balance between chromatographic separations and MS sensitivity. Since its introduction, several parameters including mobile phase composition, additive...